Literature DB >> 27041086

Pediatric Lupus Nephritis-Review of Literature.

Neha Thakur1, Narendra Rai, Prerna Batra.   

Abstract

Systemic lupus erythematous (SLE) is a multisystem autoimmune disorder characterized by immune dysregulation and formation of autoantibodies. A high index of suspicion is necessary to diagnose SLE. Children have more systemic involvement than adults. Kidney involvement is seen in a significant proportion of children. With advancement of therapy the survival rate of patients with SLE has significantly improved. Even then lupus nephritis is still the most important predictor of morbidity and mortality. Treatment of lupus nephritis is mostly derived from studies in adults as data on children is still lacking. Prednisolone and cyclophosphamide was the mainstay of treatment till now. Recently drugs like mycophenolate mofetil, azathioprine, rituximab are also being used in treatment of lupus nephritis with promising results and without significant adverse effects. In this review we will be discussing lupus nephritis, its diagnosis, pathogenesis, clinical picture and treatment advancements. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Advancements; cyclophosphamide; lupus nephritis; mofetil; mycophenolate; pediatric

Mesh:

Substances:

Year:  2017        PMID: 27041086     DOI: 10.2174/1573397112666160404124308

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  3 in total

Review 1.  A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.

Authors:  Xin Huang; Qing Zhang; Huilin Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-22       Impact factor: 8.667

2.  Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Tsung-Chieh Yao; Su-Hsun Liu; Jing-Long Huang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.

Authors:  Mileka Gilbert; Beatrice Goilav; Joyce J Hsu; Paul J Nietert; Esra Meidan; Annabelle Chua; Stacy P Ardoin; Scott E Wenderfer; Emily von Scheven; Natasha M Ruth
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-30       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.